Itraconazol Normon (Itraconazole)

Itraconazole blocks the fungal enzyme lanosterol 14α‑demethylase, a key step in ergosterol synthesis. Without ergosterol, the fungal cell membrane cannot form properly, leading to increased permeability and inhibition of fungal growth and replication.

The specific dose and duration of Itraconazol Normon are determined by the prescribing healthcare professional based on the type and severity of the infection, patient age, weight, renal and hepatic function, and other clinical factors. Patients should follow the prescriber’s instructions exactly.

Safety data for itraconazole in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and risks with their healthcare provider.

To request Itraconazol Normon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Itraconazole offers a broad spectrum against many dermatophytes and systemic fungi, often providing oral therapy where other azoles may be less effective. Compared with fluconazole, itraconazole has stronger activity against certain molds such as Aspergillus but may have more drug‑interaction potential due to CYP3A4 inhibition.

Store Itraconazol Normon at ambient temperature below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Itraconazol Normon is taken orally, usually with food to enhance absorption. The tablet or capsule should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious risks include hepatotoxicity, severe skin reactions such as Stevens‑Johnson syndrome, cardiac failure in susceptible patients, and rare visual disturbances. Patients should be monitored for signs of liver injury, rash, or heart symptoms, and any concerning signs should prompt immediate medical evaluation.

Patients with known hypersensitivity to itraconazole or any azole antifungal should avoid the product. Caution is advised for individuals with severe liver disease, uncontrolled heart failure, or those taking medications that strongly interact with itraconazole. The prescriber will assess suitability before initiating therapy.